INSULIN RESISTANCE, DIABETES & CARDIOVASCULAR DISEASE

Abstracts

Submit an Abstract Electronically

Abstract Submission Deadline: Oct. 30, 2017

  • Accepted  Abstracts will be published in Endocrine Practice, the official journal of AACE.
  • Accepted  Abstracts will  have a poster presentation at the meeting.
  • Top Abstracts will be selected for oral presentation at the meeting.
  • In some cases, the committee may consider Late Breaking Abstracts for oral presentation.

Abstract Submission & Topics:

Clinical aspects of insulin resistance in childhood, adolescence and/or adulthood pertaining to:

Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, sleep disorders such as obstructive sleep apnea

Basic science:

Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain

Guidelines:

Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease.  Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence and/or adulthood in relationship to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.

The interests of the Congress include multi-hormonal aspects of obesity, incretins and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with specific relationship to insulin action and its regulation at the cellular, organ, or whole body level.

To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.

In addition:

  • Scientific materials presented at the 15th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2017)  must not have been published or presented prior to November 30, 2017, other than in abstract form.
  • All abstracts must be submitted electronically: http://wcir.org/abstracts/send-abstract/  on a Microsoft Word document of no more than 500 words and no more than 1 figure, table, or other graphic.  PDF documents will NOT be accepted, or any submissions by fax or mail.  For sample formatting, please click here.
  • All materials must arrive on or before the abstract deadline noted above.
  • Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.
  • Authorship on multiple abstracts is permitted.
  • All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
  • Abstracts may be submitted for poster presentation. If selected for poster presentation, the author is required to register for the Congress and to be present during the poster sessions. Awards will be given for the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mention. The authors of the winning abstracts will orally present their research findings during the Plenary Sessions in a ten minute presentation, to be followed by a five minute period of discussion.
  • If selected for oral presentation, an author is required to register for the Congress and to be prepared for the oral presentation with a PowerPoint presentation.  Abstracts must be accompanied by a statement from the authors agreeing that, if chosen, they will prepare a poster presentation, and that, if awarded a high ranking, they will prepare an oral presentation.
  • Abstracts will be published in: Endocrine Practice.Editor-in-Chief – Derek Leroith, MD, PhD “Endocrine Practice is a peer-reviewed journal published six times a year, and is the official journal of the American Association of Clinical Endocrinologists (AACE). The first issue of Endocrine Practice was published in 1995. The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.”

 

Abstract Committee:

 

bloomgarden-zachary-web-pictureZachary T. Bloomgarden, MD
Clinical Professor of Medicine, Mount Sinai School of Medicine
Assistant Attending in Medicine, Mount Sinai Hospital
Consultant in Endocrinology
Lawrence Hospital
New York, New York
———————-


levyPhilip Levy, MD, MACE
Clinical Professor of Medicine,
University of Arizona College of Medicine
Endocrinologist, Banner University Medical Group,
Phoenix, Arizona
———————-
———————-


einhorn-danielDaniel Einhorn, MD, FACP, FACE
Clinical Professor of Medicine
Diabetes and Endocrine Associates
Medical Director, Scripps Whittier
Institute for Diabetes
San Diego, California
———————-


George Grunberger, MDGeorge Grunberger, MD, FACP, FACE
Chairman, Grunberger Diabetes Institute
Clinical Professor, Internal Medicine and Molecular Medicine & Genetics
Wayne State University School of Medicine
Professor, Internal Medicine
Oakland University William Beaumont School of Medicine
Visiting Professor, Internal Medicine
First Faculty of Medicine, Charles University, Prague, Czech Republic
Immediate Past President, AACE
Chancellor, American College of Endocrinology
Bloomfield Hills, Michigan
———————-



Late Breaking Abstracts Accepted:

  • Accepted  Abstracts will be published in Endocrine Practice, the official journal of AACE.
  • Accepted  Abstracts will  have a poster presentation at the meeting.
  • Top Abstracts will be selected for oral presentation at the meeting.
  • In some cases, the committee may consider Late Breaking Abstracts for oral presentation.

Travel Grant Announcement:


For eligible young international physicians or researchers  2017 Poster Session participants

General Information

The WCIRDC is pleased to offer a travel grant program for international physicians who are practicing outside of the United States of America (USA). The goal of this program is to provide financial support in the form of travel grants (up to $500) to international physicians so they will have an opportunity to present a poster at the 2017 WCIRDC Annual Meeting in California at the Nov. 30 – Dec. 2nd, 2017

There will be 3 total grants awarded. Each grant award is based on a general criteria.

Criteria

  • Applicant must be younger than 35 years of age.
  • Applicant is presenting a poster at the 2017 Annual Meeting Poster Session, and has not have presented prior to November 30, 2017
  • Past WCIRDC “Travel Grant” award recipients are not allowed to apply again.
  • Participation will have a positive effect on the applicant’s career.
  • Abstract (poster) will have a significant impact on the WCIRDC Annual Meeting.

Session’s Content

Award Recipients of the International Travel Grant for Physicians will receive an amount, to be determined, for travel expenses (up to $500). The awardees will be notified in writing via e-mail or fax.

Apply Here

 

To request a invitation letter for Visa purposes click HERE